FDA

Boston Tech

Spero Therapeutics Won FDA Approval for an Oral Carbapenem. Cambridge Just Sent the IV Pole Home.

Spero Therapeutics won FDA approval for the first oral carbapenem in the U.S., giving Cambridge biotech a real answer to hospital-only UTI care.